False positives in MALDI-TOF detection of ERbeta in mitochondria.

Biochem Biophys Res Commun

Department of Biosciences and Nutrition, Karolinska Institutet/NOVUM, Hälsovägen 7, S-141 86 Huddinge, Sweden.

Published: May 2006

Recently, Yang et al. reported that estrogen receptor beta (ERbeta) is a mitochondrial protein rather than a nuclear receptor. Because this claim would lead to a significant change in our understanding of estrogen signaling, we have attempted to reproduce the MALDI-TOF data of Yang et al. We separated proteins extracted from mouse liver mitochondria by SDS-PAGE and analysed a gel band covering the molecular weight range of 50-65 kDa by MALDI-TOF/TOF. Analysis of the data with the MASCOT database algorithm provided no evidence for the presence of ERbeta in the mitochondria. If we search (as the authors did) with only the peptide masses which match to tryptic fragments of ERbeta, ERbeta is identified with a significant score of 69. However, fragmentation of these peptides shows that they are not from ERbeta. Our conclusion is that ERbeta cannot be identified by MALDI-TOF from a mixture of mitochondrial proteins resolved on SDS-PAGE.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2006.02.164DOI Listing

Publication Analysis

Top Keywords

erbeta mitochondria
8
erbeta identified
8
erbeta
7
false positives
4
positives maldi-tof
4
maldi-tof detection
4
detection erbeta
4
mitochondria yang
4
yang reported
4
reported estrogen
4

Similar Publications

Unveiling FOXO3's metabolic contribution to menopause and Alzheimer's disease.

Exp Gerontol

January 2025

Department of Biological Sciences, University of Limerick, Limerick V94 T9PX, Ireland. Electronic address:

The increasing prevalence of Alzheimer's disease (AD) calls for a comprehensive exploration of its complex etiology, with a focus on sex-specific vulnerability, particularly the heightened susceptibility observed in postmenopausal women. Neurometabolic alterations during the endocrine transition emerge as early indicators of AD pathology, including reduced glucose metabolism and increased amyloid-beta (Aβ) deposition. The fluctuating endocrine environment, marked by declining estradiol levels and reduced estrogen receptor beta (ERβ) activity, further exacerbates this process.

View Article and Find Full Text PDF

Estrogen is an essential hormone for the development and functional activities of reproductive organs. Recent studies showed that estrogen signaling is also an important regulator of lipid and glucose metabolism in a number of tissues, but the molecular mechanism is not fully understood. We report here that estrogen is a stimulator of brain-derived neurotrophic factor (BDNF) synthesis in the skeletal muscle.

View Article and Find Full Text PDF

Mitophagy, the process by which cells eliminate damaged mitochondria, is mediated by PINK1 (PTEN induced kinase 1). Our recent research indicates that PINK1 functions as a tumor suppressor in colorectal cancer by regulating cellular metabolism. Interestingly, PINK1 ablation activated the NLRP3 (NLR family pyrin domain containing 3) inflammasome, releasing IL1B (interleukin 1 beta).

View Article and Find Full Text PDF
Article Synopsis
  • Estrogen deficiency in postmenopausal mice leads to mitochondrial defects and cognitive decline associated with Alzheimer's disease, prompting research on estrogen receptor β (ERβ) as a potential protective factor.
  • The study used ovariectomized 3xTg-AD mice, with some treated with an ERβ agonist, to assess cognitive function and measure numerous proteins linked to mitochondrial health and neuronal apoptosis.
  • Findings revealed that reducing ERβ expression led to cognitive impairment and increased mitochondrial damage, while the ERβ agonist helped alleviate cognitive decline and improve mitochondrial function, suggesting ERβ's key role in neural protection against AD.
View Article and Find Full Text PDF

Objectives: To investigate the effect of Chinese medicine He's Yangchao recipe on premature ovarian insufficiency (POI) and its relationship with mitochondrial function of ovarian granulose cells in an animal model.

Methods: Thirty-six female C57BL/6J mice were randomly divided into blank control group, model group, low-, medium- and high-dose He's Yangchao recipe treatment group and coenzyme Q10 (Q10) treatment group (positive control). The POI model was induced by a single intraperitoneal injection of cyclophosphamide (90 mg/kg).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!